Candan Hızel Perry upon receiving his PhD in Cellular/Molecular biology and Human Medical Genetics in 1991 at the university of Blaise Pascale in Clermont-Ferrand in France, he completed his higher doctorate “state doctorate” (HDR – habilitation to conduct research) in 2006 in New Genetics & Drug Metabolizing Enzymes at the University of Auvergne in Clermont-Ferrand in France.  Between 2007 and 2009, he did his postdoctoral training in clinical pharmacology at Yeditepe University, School of Medicine in Istanbul. He has more than 18 years of experience in personalized medicine, including pharmacogenomics (PGx) association studies, drug target discovery, biomarker research, clinical diagnostics, health information technology in both high-income country (HIC) and in low-and middle-income country (LMIC) settings. Additionally, He has expertise in start-up biotechnology industry with a specific focus on PGx testing design, as well as genetic testing for multifactorial and polygenic diseases. Accordingly, between 1999 and 2005, he was research director and vice-president within the R&D department of a genomics/PGx bioinformatics consulting company in Clermont-Ferrand/France and in Montreal/Canada, respectively. In these companies He was responsible for providing and processing genomics/PGx information and production of personalized patient reports based on clinical/medical information and PGx test results by using expert system (ES) allowing automatic processing of genomics/PGx association data. First time in Turkey in 2006, he initiated the implementation of PGx education into curriculum of the faculty of medicine and pharmacy. He promoted and strengthened interdisciplinary training and education in personalized medicine and in PGx in various academic institutions in France (Clermont-Ferrand), Turkiye (Istanbul, Eskisehir) , in Northern Cyprus (Nicosia) and Canada (Montreal). In 2010, as principal investigator he was involved in the realization of PGx and drug safety – Pharmacogenovigilance unit under the Faculty of Pharmacy at Marmara University in Istanbul. Between 2011 and 2016 I spearheaded the implementation of center of excellence on “Personalized Medicine and Pharmacogenomics Research Centre-BIGEM and BIFAGEM” at Anadolu University in Eskisehir and Dokuz Eylül University in Izmir, Turkiye, respectively. He organized several international meetings on Personalized Medicine, in France (Vichy) in Turkiye (Istanbul, Eskisehir) as well as he has participated in the organization of international meetings in PM in Canada (Montreal).